FDA Approves New Prostate Cancer Drug Therapy | AHN

Links shared publicly online about this topic.

  • 1,203
    total visits

FDA Approves New Prostate Cancer Drug Therapy | AHN

allheadlinenews.com

FDA Approves New Prostate Cancer Drug Therapy

View full resource at allheadlinenews.com

Tags: Cancer, Cancer Medication, Prostate Cancer, Prostate Cancer Medication, Prostate, Drug, Men's Health, FDA

  • Share

Most Recently Shared on April 30, 2010 at 10:53 am By:

prostatecancer_ Prostate Cancer

FDA Approves New Prostate Cancer Drug Therapy http://bit.ly/d2rdOm

2 years ago...

FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy

drugs.com — “Prolia (denosumab) is used in the treatment of bone loss in patients with prostate or breast cancer undergoing hormone ablation therapy. Includes Prolia side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on September 20, 2011 at 1:04 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prosta... http://t.co/vescEIgy #drug

8 months ago...

Food And Drug Administration Approves Abiraterone For Treatment Of Men With Advanced Prostate Cancer

medicalnewstoday.com — “The Food and Drug Administration (FDA) on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers. It improves, by nearly four months, the overall survivalView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 2:07 pm By:

prostatediaries john clay mchugh Surgeon, Urologist, Physician, and Doctor

Food And Drug Administration Approves Abiraterone For Treatment Of Men With Advanced Prostate Cancer: The Food a... http://bit.ly/iYK60J

1 year ago...

Food And Drug Administration Approves Abiraterone For Treatment Of Men With Advanced Prostate Cancer

medicalnewstoday.com — “The Food and Drug Administration (FDA) on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers. It improves, by nearly four months, the overall survivalView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 12:05 pm By:

mnt_prostate MNT Prostate News Health News

Food And Drug Administration Approves Abiraterone For Treatment Of Men With Advanced Prostate Cancer http://mnt.to/3VjS #prostate

1 year ago...

FDA approves new targeted therapy to treat men with advanced prostate cancer

news-medical.net — “The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 7:56 am By:

prostatecancers News-Medical.Net Health News

Prostate Cancer: FDA approves new targeted therapy to treat men with advanced prostate cancer: The Food and Drug... http://bit.ly/kI3jac

1 year ago...

Medical News: FDA Okays New Drug for Advanced Prostate Ca - in Public Health & Policy, FDA General from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved abiraterone acetate (Zytiga) for treatment of late-stage, castration-resistant prostate cancer as a combination therapy with prednisone in patients who have receivedView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on April 29, 2011 at 4:55 pm By:

FightCancer FightCancer Health News

FDA Okays New Drug for Advanced Prostate Ca http://bit.ly/k4ZqIh

1 year ago...

UPDATE 2-FDA approves J&J advanced prostate cancer drug | Reuters

reuters.com — “* To be sold under brand name Zytiga * Prolonged survival by 4 months in pivotal trial * Sales expected to exceed $1 billion (Adds sales projection, approval details, background) NEW YORK, AprilView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 28, 2011 at 7:51 pm By:

prostatecancer_ Prostate Cancer Support

FDA approves J&J advanced prostate cancer drug http://bit.ly/mMYcsn

1 year ago...

FDA CONSUMER HEALTH INFORMATION - FDA Approves New Prostate Cancer Therapy - Health News - redOrbit

redorbit.com — “SILVER SPRING, Md., May 5 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has approved a new treatment for certain men with advanced prostate cancer. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Called Provenge (sipuleucel-T), the treatment stimulates a patient's own immune system to respond against the cancer. Learn more about FDA's approval of Provenge at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm210620 Sign up for e-mail notices of new FDA Consumer UView full resource at redorbit.com

  • View Related
  • Share

Most Recently Shared on May 11, 2010 at 8:26 pm By:

Healthy4you Mark Erichsen Health Advocate

FDA CONSUMER HEALTH INFORMATION - FDA Approves New Prostate Cancer ...: SILVER SPRING, Md., May 5 /PRNewswire-USNe... http://bit.ly/crFCJN

2 years ago...

Flesh and Stone - FDA approves a cellular immunotherapy for men with advanced prostate cancer

fleshandstone.net — “The U.S. Food and Drug Administration on Tuesday approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.View full resource at fleshandstone.net

  • View Related
  • Share

Most Recently Shared on April 30, 2010 at 11:08 am By:

stonekat stonekat Health Communicator and Health News

FDA approves a cellular immunotherapy for men with advanced prostate cancer http://goo.gl/fb/gctiX #pressreleases

2 years ago...

Provenge cellular immunotherapy for men with advanced prostate cancer receives FDA approval

news-medical.net — “The U.S. Food and Drug Administration today approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 30, 2010 at 6:10 am By:

prostatecancers News-Medical.Net Health News

Prostate Cancer: Provenge cellular immunotherapy for men with advanced prostate cancer receives FDA approval: The ... http://bit.ly/aHUJZR

2 years ago...

FDA approves breakthrough cancer therapy Provenge - Yahoo! News

news.yahoo.com — “A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval Thursday, offering an important alternative to more intensive treatments like chemotherapy.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on April 29, 2010 at 7:08 pm By:

HealthNewsNow Health News Now Health News

FDA approves new drug for advanced prostate cancer (AP) http://bit.ly/aKHYqZ

2 years ago...

Prostate Cancer Vaccine: FDA May Approve Provenge This Week - ABC News

abcnews.go.com — “The FDA this week is expected to approve a prostate cancer vaccine therapy that has extended the lives of some patients. Dr. Richard Besser, ABC News' senior health and medical editor, explains how the drug works.View full resource at abcnews.go.com

  • View Related
  • Share

Most Recently Shared on April 26, 2010 at 12:39 pm By:

SusanS_Health Susan Scroggins Active Health Library and Health Advocate

FDA May Approve Cancer Vaccine: The FDA this week is expected to approval a prostate cancer vaccine therapy that h... http://bit.ly/aVlbBi

2 years ago...

Advertisement